Skip to main content
. Author manuscript; available in PMC: 2016 Sep 16.
Published in final edited form as: Int Urogynecol J. 2016 Mar 18;27(9):1423–1429. doi: 10.1007/s00192-016-3000-1

Table 1.

Demographics

All women (n = 199) Vaginal estrogen (n = 134) No vaginal estrogen (n = 65)
Age 76.0 (66.0–84.0) 76.5 (66.0–86.0) 75.0 (67.0–82.0)
Body mass index 25.7 (23.4–28.7) 25.8 (23.2–28.5) 25.7 (23.7–30.1)
Race
 White 187 (94.0) 128 (95.5) 59 (90.8)
 Black 2 (1.0) 1 (0.7) 1 (1.5)
 Asian 0 (0.0) 0 (0.0) 0 (0.0)
 Other 5 (2.5) 3 (2.2) 2 (3.1)
 Unknown 5 (2.5) 2 (1.5) 3 (4.6)
Ethnicity
Hispanic 2 (1.0) 0 (0.0) 2 (3.1)
Not Hispanic 192 (96.5) 132 (98.5) 60 (92.3)
Unknown 5 (2.5) 2 (1.5) 3 (4.6)
Marital status
 Single 11 (5.5) 9 (6.7) 2 (3.1)
 Married/partner 88 (44.2) 59 (44.0) 29 (44.6)
 Divorced/separated 23 (11.6) 12 (9.0) 11 (16.9)
 Widowed 48 (24.1) 33 (24.6) 15 (23.1)
 Unknown 29 (14.6) 21 (15.7) 8 (12.3)
Smoking status
 Current smoker 7 (3.5) 6 (4.5) 1 (1.5)
 Former smoker 61 (30.7) 41 (30.6) 20 (30.8)
 Never smoker 130 (65.3) 86 (64.2) 44 (67.7)
 Unknown 1 (0.5) 1 (0.7) 0 (0.0)
Follow-up (months) 23.1 (8.7–46.3) 29.5 (11.0–55.4) 15.4 (5.5–29.4)
Diabetes
 Yes 22 (11.1) 16 (11.9) 6 (9.2)
 No 177 (88.9) 188 (88.1) 59 (90.8)
Hysterectomy
 Yes 58 (29.1) 42 (31.3) 16 (24.6)
 No 141 (70.9) 92 (68.7) 49 (75.4)
Bilateral salphingo-oophorectomy
 Yes 28 (14.1) 22 (16.4) 6 (9.2)
 No 171 (85.9) 112 (83.6) 59 (90.8)
Prolapse stage
 0 5 (2.5) 3 (2.2) 2 (3.1)
 1 16 (8.0) 12 (9.0) 4 (6.2)
 2 88 (44.2) 64 (47.8) 24 (36.9)
 3 73 (36.7) 45 (33.6) 28 (43.1)
 4 11 (5.5) 6 (4.5) 5 (7.7)
 Missing 6 (3.0) 4 (3.0) 2 (3.1)

Data are presented as median (interquartile range) or n (%)